Evaluation of miR-27a-5p and miR-449a as potential serum biomarkers for breast cancer: a combined bioinformatics and experimental study
Molecular Biology Reports · 2025-12 · 52 (1)
DOI: 10.1007/s11033-025-10705-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 13.06.2025. Verfasst von Tahereh Barati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: Breast cancer (BC) is one of the most prevalent malignancies among women worldwide, and early detection is crucial for improving patient outcomes. Among the key signaling pathways involved in BC, the MAPK signaling pathway plays a significant role in tumor progression. METHODS: Through bioinformatics analysis, we identified miRNAs associated with the MAPK signaling pathway. Differential expression analysis using microarray data from the GSE106817 and GSE113486 datasets further refined our selection. Based on these analyses, we identified two candidate miRNAs, hsa-miR-27a-5p and hsa-miR-449a, as potential biomarkers for BC. We then examined the expression levels of these two serum miRNAs in women with BC (n = 100) and healthy controls (n = 100) using RT-PCR. RESULTS: Our results demonstrated that both miRNAs were significantly upregulated in women with BC compared to healthy individuals (p < 0.05). Receiver operating characteristic (ROC) curve analysis further confirmed that these miRNAs exhibit strong diagnostic potential for BC. CONCLUSION: Overall, our findings suggest that hsa-miR-27a-5p and hsa-miR-449a, identified through bioinformatics and microarray-based expression analyses, could serve as promising biomarkers for BC detection. Their significant association with the MAPK signaling pathway was determined through bioinformatics analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of General Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. mansooris@tbzmed.ac.ir.
ORCID-Profile: Sima Mansoori Derakhshan
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Barati, T., Mirzaei, Z., Ebrahimi, A., Khaniani, M. S., Hashemi, S., Mehri, M., & Derakhshan, S. M. (2025). Evaluation of miR-27a-5p and miR-449a as potential serum biomarkers for breast cancer: a combined bioinformatics and experimental study. Molecular Biology Reports, 52(1). https://doi.org/10.1007/s11033-025-10705-x
Vancouver
Barati T, Mirzaei Z, Ebrahimi A, Khaniani MS, Hashemi S, Mehri M, et al. Evaluation of miR-27a-5p and miR-449a as potential serum biomarkers for breast cancer: a combined bioinformatics and experimental study. Molecular Biology Reports. 2025;52(1). doi:10.1007/s11033-025-10705-x
BibTeX
@article{Barati2025,
author = {Barati, Tahereh and Mirzaei, Zohreh and Ebrahimi, Amir and Khaniani, Mahmoud Shekari and Hashemi, Solmaz and Mehri, Maghsood and Derakhshan, Sima Mansoori},
title = {Evaluation of miR-27a-5p and miR-449a as potential serum biomarkers for breast cancer: a combined bioinformatics and experimental study},
journal = {Molecular Biology Reports},
year = {2025},
volume = {52},
number = {1},
doi = {10.1007/s11033-025-10705-x}
}
EUVIMED